AAOS Now / Issue
Ryan Pezold, MA
The use of MSC injections as regenerative therapy continues to grow as an area of acute interest for many clinicians and patients, despite a lack of high-quality evidence suggesting clinical efficacy.
Some AAOS Now articles are available only to AAOS members. Please log in to access this article.
Not a member? Become a member.